Presentation Information
[3P-253]Design of dual PDZ domain inhibitor for the development of anti-coronavirus drugs
○Natsuno Ando1, Takeshi Tenno1,5, Ryusei Hamajima1, Haruka Takagi1, Yuya Hanazono2, Nobutaka Numoto3, Youichi Suzuki4, Nobutoshi Ito2, Hidekazu Hiroaki1,5,6 (1. Grad. Sch. Pharm. Sci., Nagoya Univ., 2. Med. Res. Inst., Tokyo. Med. Dent. Univ., 3. Res. Inst. Int. Sci., Okayama Univ., 4. Grad. Sch. Med., Osaka. Med. Pharm. Univ., 5. BeCellbar, LLC, 6. NU-COMIT)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in